Top Midday Gainers

MT Newswires Live11-12 03:08

CERo Therapeutics (CERO) said on Monday that it presented preclinical data demonstrating the capability of its lead compound CER-1236 to kill ovarian cancer cells in preclinical models with no indications of toxicity in animal models.

Shares surged 140% as intraday trading volume soared to more than 1.16 billion from a daily average of about 8.8 million.

RadNet (RDNT) shares soared as Q3 adjusted earnings and revenue reported late Sunday rose more than forecast.

Shares advanced 20% as intraday trading volume climbed to over 1.8 million from a daily average of about 523,000.

Jefferies was one of several brokerage firms to adjust its price target for Bristol-Myers Squibb (BMY). It raised the price target to $63 from $58 while maintaining the hold rating.

Shares of Bristol-Myers jumped 11%, with intraday trading volume at over 18.3 million compared with a daily average of about 10.6 million.

Price: 0.17, Change: +0.10, Percent Change: +140.00

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment